Replimune Group, Inc. (REPL) Misses Q4 EPS by 234c

Replimune Group, Inc. (NASDAQ: REPL) reported Q4 EPS of ($2.99), $2.34 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Replimune Group, Inc. (REPL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Medtronic completes $550 million Scientia Vascular acquisition